Dehydroabietic acid
CAS No. 1740-19-8
Dehydroabietic acid( —— )
Catalog No. M18122 CAS No. 1740-19-8
Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 50 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 165 | In Stock |
|
| 50MG | 248 | In Stock |
|
| 100MG | 357 | In Stock |
|
| 500MG | 845 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDehydroabietic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionDehydroabietic acid (DAA) is an EBV-EA activation inhibitor.
-
DescriptionDehydroabietic acid (DAA) is an EBV-EA activation inhibitor. DAA is a useful food-derived compound for treating obesity-related diseases, by decreasing plasma glucose, insulin levels, plasma triglyceride (TG) , and hepatic TG levels. DAA derivatives displays anti-secretory and anti-pepsin effect in animal models.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEBV
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number1740-19-8
-
Formula Weight300.44
-
Molecular FormulaC20H28O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (332.85 mM)
-
SMILESCC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)C(=O)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(E)-AG 556
AG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.
-
HKI-357
HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 (IC50s: 34 nM and 33 nM). HKI-357 suppresses EGFR autophosphorylation (at Y1068), and AKT and MAPK phosphorylation.
-
Epertinib
Epertinib (S-222611) is a novel potent, orally active, reversible EGFR and HER2 inhibitor with IC50 of 1.48, 7.15 and 2.49 nM for EGFR, HER2 and HER4, respectively.
Cart
sales@molnova.com